Study details
Enrolling now
Venous Thromboembolism Prevention in Outpatients With Glioma
University of Vermont Medical Center
NCT IDNCT05683808ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Ages
18+
Locations
1 site in VT
What this study is about
This Phase 2 study is testing Apixaban in people with astrocytoma.
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Standard assignment
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
apixaban (Factor Xa inhibitor; prevents clot formation)
Drug routes
oral
Body systems
Oncology